Most patients told they need spinal fusion are still candidates for non-surgical alternatives, including biologic disc repair, decompression, PRP, and structured rehabilitation. Candidacy depends on the pain source, disc condition, prior treatments, neurological status, and overall health. Nearly 1 in 5 patients told they need spine surgery choose not to have it.
If a surgeon has recommended fusion, the next reasonable step is determining whether you qualify for less invasive options. This FAQ answers the candidacy questions patients ask most often so you can evaluate your options before committing to an irreversible procedure. For the full clinical landscape, see our guide on 7 best spinal fusion alternatives in 2026, and review our companion resource on how to avoid spinal fusion surgery when conservative care has stalled.
Back surgery has roughly a 40% failure rate, and revision rates can exceed 20% within 10 years. Confirming candidacy for alternatives is not just a practical question — it is a long-term outcome question. Patients who evaluate their spine treatment options systematically tend to make decisions they do not later regret.
Who is a candidate for spinal fusion alternatives?
Patients with discogenic pain, annular tears, contained disc herniations, degenerative disc disease, facet-mediated pain, or chronic axial back pain are typically candidates for non-surgical alternatives. Candidacy improves when imaging confirms a structural source of pain, when conservative care has been incomplete, and when there is no severe instability or progressive neurological deficit. The presence of a surgical recommendation does not, by itself, eliminate non-surgical eligibility.
Who is not a candidate for spinal fusion alternatives?
Alternatives are not appropriate for patients with cauda equina syndrome, progressive motor weakness, fracture-related instability, spinal tumors, severe spondylolisthesis with neurological compromise, or active spinal infection. These conditions require surgical evaluation. Outside of these clinical red flags, the majority of fusion candidates remain eligible for biologic disc repair, decompression, PRP, epidural injections, structured rehabilitation, or a combination of these approaches.
How do I know if I have a structural problem that alternatives can address?
An MRI identifies the structural sources that alternatives are designed to treat: annular tears, disc herniations, disc desiccation, facet hypertrophy, and nerve root compression. A discogram or CT discogram can confirm which disc is generating pain when MRI findings are ambiguous. The key question is not whether a structural problem exists — it is whether that problem responds to a non-fusion approach. Most disc-mediated pain does.
Does failed conservative care disqualify me from advanced alternatives?
Failed conservative care does not disqualify patients from biologic disc repair or other advanced alternatives — in fact, it often strengthens candidacy. Among patients who have exhausted basic conservative care, 80% of failed back surgery patients reported positive outcomes with intra-annular fibrin injection, and 70% patient satisfaction has been documented at 2-year follow-up, though individual outcomes vary. Patients who have tried physical therapy and injections without lasting relief are precisely the population these procedures were developed for.
Am I a candidate if I have already had a previous spine surgery?
For many patients, yes. Patients with failed back surgery syndrome — which affects roughly 40% of back surgery patients — are frequently candidates for biologic disc repair targeting adjacent or untreated levels. Prior surgery alters the anatomy and risk profile, so evaluation is more individualized. A previous operation does not automatically rule out fibrin disc treatment, PRP, or decompression. Imaging and a thorough clinical evaluation determine eligibility.
Clinical Note
In our clinical experience, patients with a prior fusion are among the most underserved in spine care. They are often told there are no remaining options — but that is not always accurate. When residual or adjacent disc tears are identified on imaging, intra-annular fibrin injection addresses the underlying tear rather than adding another level of hardware. The evaluation is more nuanced after a prior surgery, but it is a conversation worth having. A clinical evaluation is the only way to know for certain what options remain.
What disqualifies someone from biologic disc repair specifically?
Biologic disc repair is generally not appropriate for fully collapsed disc spaces, severe end-stage degeneration with bone-on-bone contact, large extruded fragments requiring decompression, active infection, untreated coagulopathy, or pregnancy. Severe central stenosis with neurological compromise also shifts the approach toward decompression-first strategies. Most patients referred for fusion do not meet these exclusions, but a clinical evaluation is the only way to know for certain.
How does age affect candidacy?
Age alone is rarely the deciding factor. Disc condition, overall health, and neurological status matter more than chronological age. For patients in their 60s and 70s, biologic disc repair, decompression, and PRP remain available options when imaging supports them. Conversely, a younger patient with end-stage degeneration may have fewer non-surgical options. Candidacy is anatomical, not generational.
Do I have to exhaust every conservative treatment before exploring alternatives?
No. The traditional step-care sequence — medications, physical therapy, injections, then surgery — was designed before biologic options existed. Patients who have completed a reasonable trial of conservative care, typically 6–12 weeks, can move to advanced alternatives when imaging and symptoms support it. Waiting years before considering biologic disc repair is not the standard of care for patients with confirmed disc pathology.
How important is a second opinion before committing to fusion?
A second opinion is a critical step. Surgical recommendations vary widely between providers, and a non-surgical spine specialist evaluates the same imaging with a different clinical lens. A review focused on alternatives — including understanding what spinal fusion involves and what it does not address — often surfaces options the original consultation did not include. Patients who skip this step are more likely to proceed with fusion before confirming it is truly necessary. For a broader look at decisions that delay recovery, see our resource on common spine treatment mistakes patients make before surgery.
What is the first step if I want to explore alternatives?
The starting point is a consultation and MRI review with a provider who specializes in non-surgical disc treatment. Existing imaging is reviewed to identify whether disc tears, herniations, or related structural sources of pain are present. If imaging suggests a candidate for intra-annular fibrin injection, a diagnostic annulogram is used to map every tear before any treatment decision is made. A clinical evaluation is the only way to know for certain which options apply to your specific anatomy and history.
Frequently Asked Questions
Can I be a candidate for biologic disc repair if my MRI shows multiple disc levels affected?
Multi-level disc involvement does not automatically exclude candidacy. The annulogram used prior to the fibrin procedure identifies which specific levels are generating pain, so treatment is targeted rather than applied broadly. Individual anatomy and degree of degeneration at each level are assessed during evaluation.
Is intra-annular fibrin injection the same as a steroid injection?
No. Epidural steroid injections deliver anti-inflammatory medication into the epidural space and do not address disc tears. The fibrin procedure uses an FDA-approved fibrin sealant injected directly into the disc through a thin catheter to seal annular tears at the structural level. An AAFP systematic review found epidural steroid injections not effective for chronic low back pain; the fibrin procedure is designed to address the underlying tear rather than suppress inflammation.
How long does the fibrin procedure take, and is it outpatient?
The procedure is performed under imaging guidance, takes under one hour, and requires no surgical incisions. It is done with local anesthetic or light sedation and is an outpatient procedure. Most patients return home the same day.
Are veterans eligible for coverage of the fibrin procedure?
Under the Mission Act, the fibrin procedure may be a covered VA benefit when the VA cannot provide timely or appropriate care. VA coverage is determined case-by-case by the VA, not by Valor Spine. The Valor team works directly with VA referral coordinators and handles the paperwork so veterans do not have to navigate the system alone.
What outcome data exists for intra-annular fibrin injection?
More than 13,000 of these procedures have been performed nationally. Among the most-tracked outcomes — over 7,000 procedures with long-term follow-up — the success rate is 83%, and 70% patient satisfaction has been documented at 2-year follow-up. Individual outcomes vary, and these figures represent population-level data, not a personal guarantee.
What if I have been told I am too far gone for anything other than fusion?
That assessment depends entirely on the criteria used and the provider’s familiarity with non-surgical options. End-stage bone-on-bone collapse does limit non-surgical candidacy, but most patients described as “needing fusion” have disc pathology — not end-stage collapse. A second clinical evaluation focused on alternatives is the only way to confirm whether that assessment is accurate for your specific anatomy.
This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. It is not a substitute for evaluation by a qualified physician. Treatment decisions depend on your individual medical history and clinical findings. Schedule a consultation to discuss whether the procedure is right for you.
